title: [The effect of antileukemic drugs on superoxide (O2-) production by human neutrophils].
authors.forename: M
authors.initials: M
authors.lastname: Katoh
authors.forename: T
authors.initials: T
authors.lastname: Shirai
authors.forename: M
authors.initials: M
authors.lastname: Umeda
authors.forename: R
authors.initials: R
authors.lastname: Yamaguchi
authors.forename: H
authors.initials: H
authors.lastname: Kaneko
authors.forename: I
authors.initials: I
authors.lastname: Ishikawa
authors.forename: M
authors.initials: M
authors.lastname: Yamauchi
authors.forename: N
authors.initials: N
authors.lastname: Kojima
mesh_terms: D015250:Aclarubicin / Q000031:analogs & derivatives*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003561:Cytarabine / Q000031:analogs & derivatives / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000378:metabolism; D009279:Naphthacenes / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D013481:Superoxides / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D009279:Naphthacenes; C011157:aclacinomycins; D003561:Cytarabine; D013481:Superoxides; D015250:Aclarubicin; C015019:enocitabine